Simultaneously implementing pathways for improving asthma, pneumonia, and bronchiolitis care for hospitalized...

Area of Science:

• Pediatric hospital medicine
• Implementation science
• Clinical pathways

Background:

• Asthma, pneumonia, and bronchiolitis are leading causes of pediatric hospitalization in the US, incurring significant costs.
• Suboptimal clinician adoption of evidence-based guidelines contributes to adverse patient outcomes, including prolonged hospital stays and readmissions.
• A previous study demonstrated the benefits of a multicondition clinical pathway intervention in a children's hospital, but its effectiveness in community settings remains unstudied.

Purpose of the Study:

• To assess the implementation and effectiveness of a multicondition clinical pathway intervention for hospitalized children with asthma, pneumonia, or bronchiolitis in community hospitals.
• To address unique implementation barriers faced by community hospitals.

Main Methods:

• A pragmatic, hybrid effectiveness-implementation, cluster-randomized trial design.
• Community hospitals will be randomized (1:1) to either the intervention or a wait-list control group.
• Primary outcome: sustained adoption of evidence-based practices over 2 years. Secondary outcomes: hospital length of stay, ICU transfer rates, and readmission rates.

Main Results:

• The study is ongoing, with enrollment projected to complete in September 2024.
• Primary analysis is anticipated in March 2025, with results to follow.
• No results are available yet as the study is in progress.

Conclusions:

• This hybrid trial aims to provide a comprehensive understanding of the pragmatic and sustainable implementation of multicondition pathway interventions in community hospitals.
• The study will assess the impact of the intervention on patient health outcomes.
• Findings will inform future strategies for improving care for hospitalized children with common respiratory illnesses.